The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, find out about our PhD opportunities, read about how we transformed prostate cancer treatment, and hear about our Liver Cancer Appeal.
The ICR believes that life-extending therapies are an important step towards our ultimate aim – which is not only to control cancers, but to cure them.
Screening women for a wide range of known genetic risk factors could improve strategies for breast cancer prevention, a new analysis shows.
We’re searching for the brightest minds in cancer research. Our new studentships are now open.
Our PhD students make a real contribution to defeating cancer while working full-time in the lab
Our Development Office is here to help you support our work, however you choose to do so
Dr Chris Bakal is doing fundamental research into cancer – vital to finding new ways of attacking it.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Dr Angela Kukula works with pharmaceutical companies to help develop new cancer drugs, using her expertise to negotiate collaborations between the ICR and industry
We run clinical trials with The Royal Marsden – taking our lab results right to the bedside
Applications for our PhD studentships are now open. Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
Our Interim Chief Executive, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Your support can help us fight an often overlooked form of cancer, one that claims an increasingly large number of lives every year.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
Find out more about the aims and achievements of our eight scientific divisions.
RT @daninava: Cancer research is teamwork. Glad to be a part of the @ICR_London Mo team. #prostate #cancer #movember http://t.co/DqFKuQpAiu
“Three solutions to cancer’s drug resistance” – Professor Paul Workman visits China
How I convinced my audience that personalised medicine can change the world
Day three at the UK’s biggest cancer conference: clinical trials, metabolomics, and targeted therapies